Modicus Prime Joins Techstars Industries of the Future with Oak Ridge National Laboratory

Modicus Prime, the company behind the computer vision technology improving commercial production of pharmaceutical drug products, has announced it will be a member of the Techstars Industries of the Future cohort. The US Department of Energy’s Oak Ridge National Laboratory (ORNL) is a partner of the Techstars program. ORNL’s bio-scientists will be using Modicus Prime’s software and co-authoring a publication. Modicus will be joined by nine other companies who were filtered from a pool of nearly 3,000 applicants.

In addition to collaborating with ORNL, the largest science and energy laboratory in the Department of Energy system, Modicus Prime will gain access to 8,000+ founders, 5,000+ mentors, and 300+ corporate partners. “Communities are what build companies, not founders,” said Taylor Chartier, CEO and founder of Modicus Prime. “The mentor engagement and lead generation from Techstars will amplify our impact on the quality of commercial drug production.”

“Communities are what build companies, not founders. The mentor engagement and lead generation from Techstars will amplify our impact on the quality of commercial drug production.” - Taylor Chartier, CEO of Modicus Prime

About Modicus Prime

Modicus Prime’s computer vision software automates biologics image analysis and is designed to solve for the cost, legal, and waste liabilities from product quality failures across R&D and manufacturing. Modicus Prime is venture-backed and has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory (DOE), eLabNext (Eppendorf), Dotmatics, PlugandPlay Health, and Techstars. Our proprietary GxP-compliant software, mpVision, enables scientists to independently train their own AI to achieve real-time classification of any imaging data - from biologic morphology analysis to commercial contamination detection – for comprehensive quality control across R&D and manufacturing. mpVision has been globally tested by scientists at Takeda Pharmaceuticals, and its features are mapped to the unmet needs of the pharmaceutical industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs.

To learn more about Modicus Prime, please visit https://modicusprime.com.